At AC Immune, we are passionate about making a difference in the lives of people affected by Alzheimer’s and other neurodegenerative diseases. Our goal is to become the global leader in precision medicine of neurodegenerative diseases that are one of the biggest challenges facing society today and future generations.
Latest news
December 12, 2018
AC Immune and Lilly Announce License and Collaboration Agreement
News features
December 6, 2018
November 5, 2018
Company information
Discover more about us, who we are, and how we innovate to improve neurodegenerative disease understanding and develop breakthrough therapies.
Product pipeline
One of the world’s largest Alzheimer’s product pipelines with complementary diagnostic agents driven by proprietary technology platforms.
